Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways

International Journal of Molecular Medicine
Bo'an ZhengXiaojun Yu

Abstract

Colorectal cancer, also known as colon cancer is the most devastating malignancy worldwide. Previous studies have reported that Nit2, a member of the nitrilase superfamily, is a potential tumor suppressor, although its function remains elusive in colon cancer. In the present study, we employed an RNA interference lentivirus system to silence endogenous NIT2 expression in the colon cancer cell line, HCT116. The knockdown efficiency was determined by RT-qPCR and western blot analysis. The depletion of NIT2 markedly inhibited colon cancer cell proliferation and colony formation and induced cell cycle arrest in the G0/G1 phase, as shown by MTT assay, colony formation assay and flow cytometric analysis, respectively. Further investigation with an intracellular signaling array demonstrated that the depletion of NIT2 triggered the apoptosis of colon cancer cells through the caspase-3 and poly(ADP-ribose) polymerase (PARP) pathways. Our findings suggest that NIT2 may be an oncogene in human colon cancer and may thus serve as a promising therapeutic target for the treatment of colon cancer.

References

Jul 20, 1971·Biochemistry·L B Hersh
Oct 18, 1996·Cell·E S AlnemriJ Yuan
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y PekarskyC M Croce
Sep 6, 2001·Genome Biology·H C Pace, C Brenner
Aug 5, 2003·Molecular and Cellular Biology·Arnaud ParcellierCarmen Garrido
Dec 4, 2003·Current Opinion in Cell Biology·Kelly M Boatright, Guy S Salvesen
Dec 28, 2004·Nature Biotechnology·Dong-Ho KimJohn J Rossi
Nov 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Seong-Woon YuValina L Dawson
May 10, 2007·The FEBS Journal·Chun-Hung LinChin-Hsiang Chien
Jan 1, 2008·Current Gerontology and Geriatrics Research·Tatiana S PiskunovaVladimir N Anisimov
May 12, 2009·Neurochemistry International·Monika Szeliga, Marta Obara-Michlewska
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Sep 10, 2009·Cell·Manabu Kurokawa, Sally Kornbluth
Oct 1, 2009·The Biochemical Journal·Jad WaltersA Clay Clark
Mar 23, 2010·Lancet·David CunninghamNaureen Starling
Mar 26, 2010·Journal of Cancer Research and Clinical Oncology·Wenhao GuoYou Lu
Sep 14, 2010·Cancer Cell·Jian-Bin WangRichard A Cerione
Nov 26, 2010·Annual Review of Pathology·Eric R Fearon
Dec 3, 2010·Current Opinion in Genetics & Development·John Brognard, Tony Hunter
Jan 15, 2011·Oncotarget·Jon W Erickson, Richard A Cerione
Feb 8, 2011·Analytical and Bioanalytical Chemistry·Tomiko KuharaArthur J L Cooper
Jun 5, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Makito MiyakeCharles J Rosser

❮ Previous
Next ❯

Citations

May 18, 2016·Cancer Biotherapy & Radiopharmaceuticals·Shang-Hang ShenZhan-Xiang Wang
Aug 8, 2019·G3 : Genes - Genomes - Genetics·Michael D RotelliBrian R Calvi
Jan 12, 2020·Molecular Biology Reports·Shan ChenChongjin Feng
Mar 12, 2016·Oncotarget·Yong Antican WangBo Lu
Nov 10, 2018·Journal of Oncology·Patricia Sanmartín-Salinas, Luis G Guijarro
Dec 23, 2020·Analytical Biochemistry·Thambi DoraiArthur J L Cooper
Aug 16, 2021·Analytical Biochemistry·Ekaterina Yu EpovaBoris F Krasnikov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.